Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Equivalence of GSK2340272A and GSK2340274A H1N1 Influenza Vaccines
NCT00979407Phase 3Completed
- Sponsor
- GSK
- Start
- Oct 2009
- Primary completion
- Nov 2009
- Modality
- Whole Inactivated Vaccines
- Countries
- 2
01
Overview
A Phase 3 trial of Q-Pan H1N1, influenza vaccine (split virion, inactivated, H1N1) in influenza, sponsored by GSK. Started Oct 2009; status: completed.
02
Drugs
Q-Pan H1N1influenza vaccine (split virion, inactivated, H1N1)
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00979407.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00979407.